Schizophrenia Research and Treatment / 2012 / Article / Tab 1 / Review Article
Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review Table 1 Characteristics of some older and newer LAIs [
12 ,
17 ,
19 ].
Vehicle Preparation Dosing interval Injection site pain/reactions Comments Flupenthixol Ester (decanoate) Viscoleo 2–4 w + + + [20 , 21 ]— Fluphenazine Ester (decanoate) Sesame seed oil 2–5 w + + + [20 , 21 ]— Haloperidol Ester (decanoate) Sesame seed oil 4 w + + + [20 –22 ]— Zuclopenthixol Ester (decanoate) Viscoleo 2–4 w + + + + [20 , 21 ]— Paliperidone Ester (palmitate) Water (nanosuspension) 4 w + + [23 ]Metabolite of risperidone Olanzapine Salt (pamoate) Water (microcrystalline suspension) 2–4 w + + [24 , 25 ]Monitoring required for at least three hours due to small risk of IAIV Risperidone Microspheres Water 2 w + [23 , 26 , 27 ]Refrigeration required
IAIV: inadvertent intravascular injection; + : minimal; + + : low; + + + : moderate; + + + + : high.